May IgG4-related disease be reactivated by SARS-CoV-2 infection?
Reumatologia（2022）
摘要
Patients with inflammatory rheumatic diseases are at high risk for severe outcomes associated with coronavirus disease 2019 (COVID-19) due to the immune disturbances related to the disease, administration of immuno- suppressive drugs and comorbidities [1, 2].
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要